tiprankstipranks
Trending News
More News >
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Japanese Market
Advertisement

Cosmo Bio Co., Ltd. (3386) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Cosmo Bio Co., Ltd. has a market cap or net worth of ¥6.83B. The enterprise value is ¥4.93B.
Market Cap¥6.83B
Enterprise Value¥4.93B

Share Statistics

Cosmo Bio Co., Ltd. has 6,048,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,048,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

Cosmo Bio Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.20%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.20%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee57.68M
Profits Per Employee1.51M
Employee Count174
Asset Turnover0.86
Inventory Turnover6.30

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio27.7
PS Ratio0.00
PB Ratio0.77
Price to Fair Value0.70
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-5.11

Income Statement

In the last 12 months, Cosmo Bio Co., Ltd. had revenue of 10.04B and earned 262.00M in profits. Earnings per share was 45.05.
Revenue10.04B
Gross Profit3.33B
Operating Income318.00M
Pretax Income369.00M
Net Income262.00M
EBITDA455.00M
Earnings Per Share (EPS)45.05

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Cosmo Bio Co., Ltd. pays an annual dividend of ¥61, resulting in a dividend yield of 5.2%
Dividend Per Share¥61
Dividend Yield5.2%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.28
52-Week Price Change40.21%
50-Day Moving Average1.16K
200-Day Moving Average1.11K
Relative Strength Index (RSI)55.89
Average Volume (3m)3.22K

Important Dates

Cosmo Bio Co., Ltd. upcoming earnings date is Aug 5, 2025, TBA (Confirmed).
Last Earnings DateMay 9, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateJun 27, 2025

Financial Position

Cosmo Bio Co., Ltd. as a current ratio of 6.20, with Debt / Equity ratio of 3.94%
Current Ratio6.20
Quick Ratio5.29
Debt to Market Cap<0.01
Net Debt to EBITDA-5.22
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Cosmo Bio Co., Ltd. has paid 99.00M in taxes.
Income Tax99.00M
Effective Tax Rate0.27

Enterprise Valuation

Cosmo Bio Co., Ltd. EV to EBITDA ratio is 8.61, with an EV/FCF ratio of 156.79.
EV to Sales0.39
EV to EBITDA8.61
EV to Free Cash Flow156.79
EV to Operating Cash Flow16.26

Balance Sheet

Cosmo Bio Co., Ltd. has ¥2.69B in cash and marketable securities with ¥20.00M in debt, giving a net cash position of -¥2.67B billion.
Cash & Marketable Securities¥2.69B
Total Debt¥20.00M
Net Cash-¥2.67B
Net Cash Per Share-¥441.96
Tangible Book Value Per Share¥1.61K

Margins

Gross margin is 33.39%, with operating margin of 3.17%, and net profit margin of 2.61%.
Gross Margin33.39%
Operating Margin3.17%
Pretax Margin3.68%
Net Profit Margin2.61%
EBITDA Margin4.53%
EBIT Margin3.18%

Analyst Forecast

The average price target for Cosmo Bio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast7.74%
EPS Growth Forecast-39.17%

Scores

Smart ScoreN/A
AI Score64
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis